Multiple sclerosis treatment in Jordan

Multiple sclerosis treatment is a long-term medical plan for an immune-mediated disease in which the immune system attacks the myelin sheath around nerves in the brain, spinal cord and optic nerve. Nerve signalling is disrupted, producing symptoms such as weakness or numbness of a limb, imbalance, double vision or painful loss of vision in one eye, profound fatigue, muscle spasticity and bladder problems. **This is a disease that is managed, not cured.** The goals are to reduce the number and severity of relapses, slow the accumulation of disability, control day-to-day symptoms and preserve function — not to promise recovery. The plan rests on four pillars that work together. The first is disease-modifying therapy, given continuously to reduce the immune activity directed against nerve tissue; the choice is made by the neurologist according to disease activity, other medical conditions and pregnancy plans. The second is treatment of an acute relapse when one occurs. The third is symptom management: spasticity, fatigue, neuropathic pain, bladder and bowel problems, walking difficulty, and changes in concentration and memory. The fourth is neurological rehabilitation — physiotherapy, occupational therapy and speech therapy when needed — alongside psychological and vocational support, because this disease affects people in their working and family years. The limits must be stated plainly. No treatment today ends the disease, and disease-modifying therapy works on the future rather than on damage already done; function that has been permanently lost is addressed by rehabilitation through adaptation and strengthening what remains, not by restoring it as it was. An MRI with no new lesions does not mean the disease has stopped for good, and the reverse also happens: a new lesion may appear without symptoms. One point is widely misunderstood — a rise in body temperature from fever, a hot bath or hot weather can temporarily bring back old symptoms; this is not a new relapse and it settles as the temperature returns to normal. Diagnosis and treatment eligibility are established by neurological examination, imaging and laboratory tests, not by matching symptoms found online, because many other conditions mimic multiple sclerosis at first presentation and must be excluded before starting long-term therapy. Regular follow-up is the core of the plan: comparing MRI studies over time, periodic safety blood tests, and reviewing functional goals with the patient and family. Stopping smoking, weight control and regular physical activity are supportive measures with proven value for function and general health, but they do not replace the medical plan and are not an alternative to it.